BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 19015385)

  • 21. Tissue renin-angiotensin systems in the heart and vasculature: possible involvement in the cardiovascular actions of converting enzyme inhibitors.
    Unger T; Gohlke P
    Am J Cardiol; 1990 May; 65(19):3I-10I. PubMed ID: 2159693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [What is the purpose of dual or triple inhibition of the renin-angiotensin-aldosterone system?].
    Legrand D; Krzesinski JM; Scheen AJ
    Rev Med Suisse; 2008 Aug; 4(168):1792-7. PubMed ID: 18814762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can angiotensin II type 2 receptors have deleterious effects in cardiovascular disease? Implications for therapeutic blockade of the renin-angiotensin system.
    Lévy BI
    Circulation; 2004 Jan; 109(1):8-13. PubMed ID: 14707017
    [No Abstract]   [Full Text] [Related]  

  • 24. Tissue angiotensin generation and regulation of vascular tone.
    Cockcroft JR; O'Kane KP; Webb DJ
    Pharmacol Ther; 1995 Feb; 65(2):193-213. PubMed ID: 7792315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent advances in cardiovascular pharmacology.
    Frishman WH
    Heart Dis; 1999; 1(2):68-90. PubMed ID: 11720608
    [No Abstract]   [Full Text] [Related]  

  • 26. Angiotensin II- and Alzheimer-Type Cardiovascular Aging.
    Cooper HA; Scalia R; Rizzo V; Eguchi S
    Circ Res; 2018 Aug; 123(6):651-653. PubMed ID: 30355238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pressure, platelets, and plaque: the central role of angiotensin II in cardiovascular pathology. Introduction.
    Arakawa K
    Am J Cardiol; 2001 Apr; 87(8A):1C-2C. PubMed ID: 11334761
    [No Abstract]   [Full Text] [Related]  

  • 28. [Renin-angiotensin-aldosterone system in thyroid disorders].
    Marcisz C
    Postepy Hig Med Dosw; 2000; 54(4):519-35. PubMed ID: 11016270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renin inhibition: the next step in suppression of the renin-angiotensin system?
    Azizi M
    Curr Hypertens Rep; 2007 Apr; 9(2):81-3. PubMed ID: 17442216
    [No Abstract]   [Full Text] [Related]  

  • 30. Renin-angiotensin system in human failing hearts: message from nonmyocyte cells to myocytes.
    Matsubara H
    Circ Res; 2001 May; 88(9):861-3. PubMed ID: 11348994
    [No Abstract]   [Full Text] [Related]  

  • 31. RAAS inhibition/blockade in patients with cardiovascular disease: implications of recent large-scale randomised trials for clinical practice.
    Pitt B
    Heart; 2009 Aug; 95(15):1205-8. PubMed ID: 19401281
    [No Abstract]   [Full Text] [Related]  

  • 32. Therapeutic efficacy of renin-angiotensin blockade in patients receiving dialysis.
    Suzuki H
    Ther Adv Cardiovasc Dis; 2009 Oct; 3(5):397-405. PubMed ID: 19491138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Where does the evidence lead us for the proper use of angiotensin II inhibitors in the management of cardiovascular disease?
    Guthrie RM
    Cardiology; 2010; 117(3):216-8. PubMed ID: 21160183
    [No Abstract]   [Full Text] [Related]  

  • 34. The Renin Report.
    Sica DA; Ichihara A
    J Renin Angiotensin Aldosterone Syst; 2006 Dec; 7(4):247-51. PubMed ID: 17347934
    [No Abstract]   [Full Text] [Related]  

  • 35. [involvement of chymase in pathogenesis of cardiovascular diseases].
    Urata H
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():147-51. PubMed ID: 15171359
    [No Abstract]   [Full Text] [Related]  

  • 36. Blocking the renin-angiotensin system: dual- versus mono-therapy.
    Ravandi A; Teo KK
    Expert Rev Cardiovasc Ther; 2009 Jun; 7(6):667-74. PubMed ID: 19505282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Regional distribution and function of brain renin angiotensin system].
    Yoshimi H
    Nihon Rinsho; 1990 May; 48(5):1023-30. PubMed ID: 2198355
    [No Abstract]   [Full Text] [Related]  

  • 38. Renin angiotensin aldosterone inhibition in the treatment of cardiovascular disease.
    Ferrario CM; Mullick AE
    Pharmacol Res; 2017 Nov; 125(Pt A):57-71. PubMed ID: 28571891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Intracellular signal transduction of angiotensin II and possible interventions in the renin-angiotensin system].
    Schmitz U; Vetter H; Düsing R
    Dtsch Med Wochenschr; 2002 Nov; 127(45):2400-3. PubMed ID: 12422300
    [No Abstract]   [Full Text] [Related]  

  • 40. [Renin-angiotensin system blockers].
    Dimitrov T
    Eksp Med Morfol; 1982; 21(2):49-54. PubMed ID: 6183092
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.